What Explains the Delay in Releasing Results of the NR / Long COVID Clinical Study?

We all know someone suffering from Long COVID. And, if you’re like me, you’ve been waiting patiently for results of the Harvard/MGH Long COVID clinical study (Details) evaluating NAD+ boosting supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes) as a possible treatment. So, what’s the status of the study? Chromadex CEO Rob Fried explained during an investor presentation at the end of August:

Video embedded below:

HOST:

“Do you anticipate the Long COVID clinical results to be made available before possible review completion by the FDA?

Chromadex CEO Rob Fried:

“The study has been completed.

It was done at Harvard and overseen by Dr. Rudy Tanzi, our SAB (Scientific Advisory Board) member (More on Dr. Tanzi).

We have no idea what the results are.

It was a completely blinded study.

The last few months have been frustratingly time consuming.

They’re measuring the NAD metabolome.

We still haven’t seen the results.

They had to wait on a long waiting list at City of Hope to get the NAD metabolome measured.

And that’s essentially what we’re waiting for.

It’s technically a Phase 4 clinical study.

But that’s a technicality because Long COVID is technically not a disease.

These are people who tested negative for COVID.

And yet they’re being tested for Long COVID which is not being classified as a disease as yet.

So, therefore they call it a Phase 4 clinical because these patients have in essence gotten past the disease.

So, we’re going to wait and see the results before we figure out our strategy going forward.

It was not a commercial IND (investigational new drug) filed for this.

And, again, Long COVID is not technically classified as a disease.

So, we have to investigate the status of Long COVID with the FDA before we decide our commercialization plans.

At a minimum, it should be very very helpful for sales of Tru Niagen (NR) if the results are positive.

But we don’t yet know the results.

I do expect to know the results by the end of the year, however”

Related:

• FAQs on the Potential for Treating Long COVID with Vitamin Supplement Nicotinamide Riboside “NR” (Link)
• Nicotinamide Riboside “NR” (FAQs) (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD